HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 106 filers reported holding HOMOLOGY MEDICINES INC in Q3 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $69,000 | -25.8% | 22,768 | -10.6% | 0.00% | – |
| Q4 2021 | $93,000 | -51.1% | 25,468 | +5.6% | 0.00% | – |
| Q3 2021 | $190,000 | +5.0% | 24,126 | -3.1% | 0.00% | – |
| Q2 2021 | $181,000 | -17.7% | 24,903 | +6.5% | 0.00% | – |
| Q1 2021 | $220,000 | -31.0% | 23,386 | -17.2% | 0.00% | – |
| Q4 2020 | $319,000 | +3.2% | 28,252 | -2.2% | 0.00% | – |
| Q3 2020 | $309,000 | +8.0% | 28,892 | +53.3% | 0.00% | – |
| Q2 2020 | $286,000 | +108.8% | 18,850 | +114.9% | 0.00% | – |
| Q1 2020 | $137,000 | -27.1% | 8,771 | -4.1% | 0.00% | – |
| Q4 2019 | $188,000 | +48.0% | 9,144 | +29.0% | 0.00% | – |
| Q3 2019 | $127,000 | -48.6% | 7,087 | -44.0% | 0.00% | – |
| Q2 2019 | $247,000 | -54.2% | 12,665 | -35.2% | 0.00% | – |
| Q1 2019 | $539,000 | +28.3% | 19,541 | +3.5% | 0.00% | – |
| Q4 2018 | $420,000 | -59.3% | 18,878 | -58.2% | 0.00% | – |
| Q3 2018 | $1,032,000 | +35.8% | 45,200 | +21.1% | 0.00% | – |
| Q2 2018 | $760,000 | – | 37,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $5,307,025 | 1.53% |
| Western Standard LLC | 250,060 | $292,570 | 0.26% |
| OUP Management Co., LLC | 64,000 | $74,880 | 0.17% |
| Vivo Capital, LLC | 370,068 | $432,980 | 0.05% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $6,611,665 | 0.04% |
| GEORGE KAISER FAMILY FOUNDATION | 39,320 | $46,004 | 0.01% |
| American Investment Services, Inc. | 36,955 | $43,238 | 0.01% |
| RBF Capital, LLC | 58,700 | $68,679 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 185,100 | $216,567 | 0.01% |
| XTX Topco Ltd | 21,188 | $24,790 | 0.00% |